Search results for "FN"

showing 10 items of 862 documents

SARS-CoV-2 Viral Load, IFNλ Polymorphisms and the Course of COVID-19: An Observational Study

2020

The course of SARS-CoV-2 infection ranges from asymptomatic to a multiorgan disease. In this observational study, we investigated SARS-CoV-2 infected subjects with defined outcomes, evaluating the relationship between viral load and single nucleotide polymorphisms of genes codifying for IFN&lambda

medicine.medical_specialtyCoronavirus disease 2019 (COVID-19)viruseslcsh:MedicineSingle-nucleotide polymorphismDiseaseSettore MED/42 - Igiene Generale E ApplicataLower riskAsymptomaticGastroenterologyArticle03 medical and health sciencessingle nucleotide polymorphisms0302 clinical medicinesingle nucleotide polymorphismSettore BIO/13 - Biologia ApplicataInterferonIFNλsInternal medicinemedicine030212 general & internal medicineskin and connective tissue diseasesCOVID-19 outcome030304 developmental biologySettore MED/12 - Gastroenterologia0303 health sciencesbusiness.industrySARS-CoV-2fungilcsh:RIFNλGeneral Medicinerespiratory tract diseasesCOVID-19 outcomesviral loadbody regionsObservational studymedicine.symptombusinessViral loadmedicine.drugJournal of Clinical Medicine
researchProduct

Association between increased arterial stiffness and clinical outcomes in patients with early sepsis: a prospective observational cohort study.

2019

Background Conduit arteries, especially the aorta, play a major role in ensuring efficient cardiac function and optimal microvascular flow due to their viscoelastic properties. Studies in animals and on isolated arteries show that acute systemic inflammation can cause aortic stiffening which affects hemodynamic efficiency. Carotid-femoral pulse wave velocity, a measure of aortic stiffness, may be useful as a bedside investigational method in patients with early sepsis admitted to intensive care, as circulatory changes can lead to multiple organ failure and increased mortality. This study aims to investigate arterial stiffness in early sepsis and its association with clinical outcomes. Metho…

medicine.medical_specialtyCritical Care and Intensive Care Medicinelaw.inventionSepsis03 medical and health sciences0302 clinical medicinelawInternal medicineIntensive careSepsismedicinePulse wave velocityPrognostic factorAPACHE IIbusiness.industryProportional hazards modelSeptic shockResearchlcsh:Medical emergencies. Critical care. Intensive care. First aidHemodynamics030208 emergency & critical care medicinelcsh:RC86-88.9medicine.diseaseIntensive care unitPulse wave velocity030228 respiratory systemCardiologyArterial stiffnessbusinessIntensive care medicine experimental
researchProduct

Is sauna bathing protective of sudden cardiac death? A review of the evidence

2019

Sudden cardiac death (SCD) is a global public health burden accounting for 15–20% of all deaths. Though established atherosclerotic risk factors explain a large proportion of the risk of SCD, these factors are often absent in a large proportion of SCD victims and the pathogenesis of SCD is still not fully established. It therefore appears that additional factors may be involved. Sauna bathing is a traditional Finnish activity that is mainly used for the purposes of relaxation and pleasure. Beyond its use for these purposes, sauna bathing has been linked with several health benefits. Emerging evidence suggests that sauna bathing is associated with reduced risk of adverse cardiovascular (CV) …

medicine.medical_specialtyDisease030204 cardiovascular system & hematologysudden cardiac deathSteam Bathlaw.inventionSudden cardiac deathCardiovascular Physiological Phenomena03 medical and health sciencesSauna bathing0302 clinical medicineRandomized controlled trialRisk FactorslawHumansMedicine030212 general & internal medicineIntensive care medicinebusiness.industryFinnish sauna bathingPublic healthArrhythmias Cardiacmedicine.diseaseDeath Sudden CardiacArterial stiffnessObservational studyGeneral healthCardiology and Cardiovascular MedicinebusinessRisk Reduction BehaviorProgress in Cardiovascular Diseases
researchProduct

Fatigue effects of marathon running on neuromuscular performance

2007

Nine experienced endurance runners performed individual marathon runs that involved several tests of neuromuscular performance before, during and after the marathon. The tests were performed with special force platform and dynamometer techniques. The results showed an overall decrease in performance from the marathon. The maximal sprint velocity decreased parabolically during the marathon, reaching the final value of 84% of the pre-marathon one. Similarly, the other test results after marathon indicated that maximal isometric knee extension torque was 78%, the performance in a special rebound test (drop jump) 84% and the 5-jump performance 92% of the pre-marathon values. These reductions we…

medicine.medical_specialtyDynamometerbusiness.industryPhysical Therapy Sports Therapy and RehabilitationIsometric exerciseMuscle stiffnessStretch shortening cyclePhysical medicine and rehabilitationSprintJumpPhysical therapyMedicineOrthopedics and Sports MedicineForce platformGround reaction forcebusinesshuman activitiesScandinavian Journal of Medicine & Science in Sports
researchProduct

Endothelial Function and Arterial Stiffness in Uncomplicated Type 1 Diabetes and Healthy Controls and the Impact of Insulin on These Parameters durin…

2007

BACKGROUND In addition to its role in glucose metabolism, insulin has shown to exert numerous vascular effects, and an impaired vascular function of insulin is assumed to be a major contributor in the development of vascular complications. Arterial augmentation (AP) and the augmentation index (Aix) are surrogate parameters of arterial stiffness and are commonly used as predictors for cardiovascular risk. The aim of this study is to investigate the effect of insulin on arterial stiffness and parameters of endothelial function in patients with type 1 diabetes and healthy control subjects. METHODS Fourteen patients with type 1 diabetes (six male, eight female) with a mean age of 36.6 +/- 11.8 …

medicine.medical_specialtyEndocrinology Diabetes and Metabolismmedicine.medical_treatmentBiomedical EngineeringBioengineering030204 cardiovascular system & hematology030218 nuclear medicine & medical imaging03 medical and health scienceschemistry.chemical_compound0302 clinical medicineDiabetes mellitusInternal medicineInternal MedicinemedicineNeurological and Microvascular FunctionType 1 diabetesbusiness.industryInsulinNitrotyrosineLitermedicine.diseasePulse pressureEndocrinologychemistryArterial stiffnessAsymmetric dimethylargininebusinessJournal of Diabetes Science and Technology
researchProduct

Addition of liraglutide in patients with Type 2 diabetes well controlled on metformin monotherapy improves several markers of vascular function

2012

Diabet. Med. 29, 1115–1118 (2012) Abstract Aims  The aim of this study was to investigate the vascular effects of liraglutide in patients well controlled on metformin monotherapy. Methods  Forty-four patients with Type 2 diabetes were included in the study. Main inclusion criteria were: pretreatment with metformin on a stable dosage, HbA1c < 53 mmol/mol (7.0%), age 30–65 years. Patients were randomized to receive additional liraglutide or to remain on metformin monotherapy. After 6 weeks (1.2 mg) and after 12 weeks (1.8 mg), venous blood was taken for the measurement of several laboratory markers characterizing vascular and endothelial function. In addition, retinal microvascular endothelia…

medicine.medical_specialtyEndotheliumbusiness.industryLiraglutideEndocrinology Diabetes and MetabolismUrologyType 2 diabetesVenous bloodmedicine.diseaseGlucagon-like peptide-1MetforminEndocrinologyEndocrinologymedicine.anatomical_structureDiabetes mellitusInternal medicineInternal MedicineArterial stiffnessmedicinebusinessmedicine.drugDiabetic Medicine
researchProduct

Effect of antihypertensive treatment with a combination of telmisartan and amlodipine on vascular structure and function

2013

medicine.medical_specialtyEndotheliumbusiness.industrymedicine.diseaseBlood pressureHYDROCHLOROTHIAZIDE/OLMESARTANmedicine.anatomical_structureInternal medicineArterial stiffnessmedicineCardiologyVascular structureAmlodipineTelmisartanEndothelial dysfunctionCardiology and Cardiovascular Medicinebusinessmedicine.drugEuropean Heart Journal
researchProduct

Pragmatic Analysis of Dyslipidemia Involvement in Coronary Artery Disease: A Narrative Review

2020

Background: Dyslipidemia is the main factor involved in the occurrence and progression of coronary artery disease. Objective: The research strategy is aimed at analyzing new data on the pathophysiology of dyslipidemia involvement in coronary artery disease, the modalities of atherogenic risk estimation and therapeutic advances. Method: Scientific articles published in PubMed from January 2017 to February 2018 were searched using the terms "dyslipidemia" and "ischemic heart disease". Results: PCSK9 contributes to the increase in serum levels of low-density lipoprotein-cholesterol and lipoprotein (a). The inflammation is involved in the progression of hyperlipidemia and atherosclerosis. Hype…

medicine.medical_specialtyFamilial hypercholesterolemiaDiseaseCoronary Artery Disease030204 cardiovascular system & hematologyArticlestatinsCoronary artery disease03 medical and health sciences0302 clinical medicineproprotein convertase subtilisin/kexin type 9Risk FactorsInternal medicineHyperlipidemiamedicineHumans030212 general & internal medicinetriglyceridesCoronary atherosclerosisDyslipidemiasbusiness.industryPCSK9dyslipidemiaGeneral Medicinemedicine.diseaseCholesterolCardiologyArterial stiffnessCardiology and Cardiovascular MedicinebusinessDyslipidemiaCurrent Cardiology Reviews
researchProduct

Is liver stiffness measurement unreliable in obese patients? authors’ reply

2011

medicine.medical_specialtyHepatologyLiver stiffnessbusiness.industryGastroenterologymedicinePharmacology (medical)businessSurgeryAlimentary Pharmacology &amp; Therapeutics
researchProduct

FNDC5 rs3480 A&gt;G polymorphism disentangles steatosis from fibrosis severity in patients with nonalcoholic fatty liver disease

2016

S. Petta1, L. Valenti2, R.M. Pipitone1, P. Dongiovanni2, C. Camma1, A.L. Fracanzani2, V. Di Marco1, M. Milano2, S. Grimaudo1, S. Fargion2, A. Craxi1 1 Section of Gastroenterology, Di.Bi.M.I.S., University of Palermo, Palermo, Italy 2 Department of Pathophysiology and Transplantation, Universita degli Studi, Internal Medicine, Fondazione Ca’ Granda IRCCS Ospedale Maggiore Policlinico, Milano, Italy

medicine.medical_specialtyHepatologybusiness.industryGastroenterologymedicine.diseaseGastroenterologyFNDC5TransplantationFibrosisInternal medicineNonalcoholic fatty liver diseaseMedicineIn patientSteatosisbusinessDigestive and Liver Disease
researchProduct